Sujets)
Adulte , Électrocardiographie , Issue fatale , Femelle , Humains , Inde , Syndrome de Lutembacher/diagnostic , Adulte d'âge moyen , Mères , Famille nucléaireSujets)
Adolescent , Angiographie , Fistule artérioartérielle/complications , Coronarographie , Anomalies congénitales des vaisseaux coronaires/complications , Vaisseaux coronaires/anatomopathologie , Échocardiographie-doppler , Électrocardiographie , Cathétérisme cardiaque , Ventricules cardiaques , Humains , Mâle , Tétralogie de Fallot/complicationsSujets)
Angioplastie coronaire par ballonnet , Association thérapeutique , Études de suivi , Humains , Infarctus du myocarde/traitement médicamenteux , Essais contrôlés randomisés comme sujet , Streptokinase/usage thérapeutique , Taux de survie , Traitement thrombolytique , Facteurs temps , Activateur tissulaire du plasminogène/usage thérapeutique , Degré de perméabilité vasculaireRésumé
The present report describes the clinical and angio-cardiographic features of 23 cases of tricuspid atresia. Nineteen patients had type I anatomy, 2 patients had type II anatomy and 2 patients had type III anatomy. In addition to the standard features, there were some uncommon associations observed. These included double outlet right ventricle, double outlet left ventricle, single coronary artery, complete heart block, right axis deviation, ostium primum atrial septal defect and coarctation of the aorta.
Sujets)
Adolescent , Angiocardiographie , Enfant , Enfant d'âge préscolaire , Femelle , Cardiopathies congénitales/classification , Valvulopathies/congénital , Ventricules cardiaques/imagerie diagnostique , Humains , Nourrisson , Mâle , Valve atrioventriculaire droite/malformationsRésumé
Selective Beta Blocker Tenolol (IPCA) 50 mg. (A50) and 100 mg. (A100) single dose drug therapy was tried in 25 cases of angina pectoris. Hypertensives were excluded from trial. There were 4 diabetics. Drug trial over a period of 4 weeks revealed subjective and objective improvement with A50 and A100 assessed at the end of 2 and 4 weeks. The average angina attacks/2 wks. was 13.12 +/- 11.26 in basal state whereas the reduction in angina attacks was 6.285 +/- 8.80 with Tenolol 50 mg. and 3.72 +/- 2.86 with 100 mg which was statistically significant. Objective assessment of each patient done by Computerised Stress Test (CST) at the end of 2 and 4 weeks of Tenolol 50 mg and 100 mg revealed statistically significant improvement in their ST depression i.e. 3.645 +/- 1.463 mm basal ST depression, 1.692 +/- 1.680 after Tenolol 50 mg and 2.318 +/- 1.270 after Tenolol 100 mg. There was statistically significant fall in systolic BP (SBP) and double product (DP) both with A50 and 100 mg. Only one patient had slow ventricular tachycardia and mild hypotension during CST.